当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 现金流量表

科伦药业

(002422)

  

流通市值:519.68亿  总市值:636.63亿
流通股本:12.99亿   总股本:15.91亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金10,473,987,3254,888,740,13421,640,073,66315,512,135,704
  收到的税费返还182,119,80029,260,900229,778,400205,102,054
  收到其他与经营活动有关的现金849,983,55592,026,541510,339,607328,836,758
  经营活动现金流入小计11,506,090,6805,010,027,57522,380,191,67016,046,074,516
  购买商品、接受劳务支付的现金4,716,828,3622,434,260,99911,438,946,6618,281,083,565
  支付给职工以及为职工支付的现金2,075,725,7971,212,096,1153,588,802,3942,805,721,976
  支付的各项税费1,113,264,500486,913,0802,365,767,1001,638,688,841
  支付其他与经营活动有关的现金1,259,100,111627,146,0642,344,607,2301,636,137,802
  经营活动现金流出小计9,164,918,7704,760,416,25819,738,123,38514,361,632,184
  经营活动产生的现金流量净额2,341,171,910249,611,3172,642,068,2851,684,442,332
二、投资活动产生的现金流量:
  收回投资收到的现金11,642,117,7567,730,308,00024,252,576,16420,206,939,312
  取得投资收益收到的现金101,088,96723,123,290170,522,117152,925,359
  处置固定资产、无形资产和其他长期资产收回的现金净额1,828,3451,447,69210,803,35411,340,699
  处置子公司及其他营业单位收到的现金净额10,800,000-11,898,47811,898,478
  投资活动现金流入小计11,755,835,0687,754,878,98224,445,800,11320,383,103,848
  购建固定资产、无形资产和其他长期资产支付的现金674,567,233412,297,3611,622,489,7291,160,484,894
  投资支付的现金13,471,430,8768,136,936,72024,109,216,40020,595,031,616
  取得子公司及其他营业单位支付的现金--2,354,95610,750,000
  投资活动现金流出小计14,145,998,1098,549,234,08125,734,061,08521,766,266,510
  投资活动产生的现金流量净额-2,390,163,041-794,355,099-1,288,260,972-1,383,162,662
三、筹资活动产生的现金流量:
  吸收投资收到的现金11,787,398-1,797,570,0521,797,570,051
  其中:子公司吸收少数股东投资收到的现金11,787,398-1,797,570,0521,797,570,051
  取得借款收到的现金3,532,109,6852,121,267,8244,656,527,8444,333,248,091
  收到其他与筹资活动有关的现金1,434,392,684483,704,507348,446,57350,938,717
  筹资活动现金流入小计4,978,289,7672,604,972,3316,802,544,4696,181,756,859
  偿还债务支付的现金2,595,950,6951,506,370,5544,671,387,9762,906,363,732
  分配股利、利润或偿付利息支付的现金984,074,76314,344,2641,331,140,7521,110,787,797
  其中:子公司支付给少数股东的股利、利润207,614,032-240,433,226240,433,306
  支付其他与筹资活动有关的现金1,135,276,11537,948,075115,986,46087,652,023
  筹资活动现金流出小计4,715,301,5731,558,662,8936,118,515,1884,104,803,552
  筹资活动产生的现金流量净额262,988,1941,046,309,438684,029,2812,076,953,307
四、汇率变动对现金及现金等价物的影响-4,887,003-806,895-45,926,939-8,625,875
五、现金及现金等价物净增加额209,110,060500,758,7611,991,909,6552,369,607,102
  加:期初现金及现金等价物余额5,936,671,7295,936,671,7293,944,762,0743,944,762,074
  期末现金及现金等价物余额6,145,781,7896,437,430,4905,936,671,7296,314,369,176
补充资料:
  净利润1,426,262,565-1,877,211,208-
  资产减值准备81,454,853-139,725,774-
  固定资产和投资性房地产折旧622,946,410-1,196,978,097-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧622,946,410-1,196,978,097-
  无形资产摊销67,118,525-126,597,495-
  长期待摊费用摊销15,943,409-20,468,303-
  处置固定资产、无形资产和其他长期资产的损失-1,680,587--5,320,176-
  固定资产报废损失6,139,738-11,010,245-
  公允价值变动损失-18,418,112--27,611,838-
  财务费用61,553,579-148,403,066-
  投资损失-117,208,645--210,412,627-
  递延所得税-23,982,672--13,121,354-
  其中:递延所得税资产减少22,812,112--32,226,652-
    递延所得税负债增加-46,794,784-19,105,298-
  存货的减少-50,925,916--158,490,254-
  经营性应收项目的减少56,887,188--37,968,987-
  经营性应付项目的增加15,213,591--676,416,316-
  其他166,788,574-174,673,294-
  现金的期末余额6,145,781,789-5,936,671,729-
  减:现金的期初余额5,936,671,729-3,944,762,074-
  现金及现金等价物的净增加额209,110,060-1,991,909,655-
公告日期2026-08-272026-04-292026-04-032025-10-31
审计意见(境内)标准无保留意见
TOP↑